Discussion Journal Article


Author: Spriggs, D. R.
Article Title: Discussion
Keywords: signal transduction; cancer survival; unclassified drug; gene mutation; gene sequence; sequence analysis; lenalidomide; disease course; cancer growth; note; cancer patient; antineoplastic agent; genetic analysis; phenotype; imatinib; bortezomib; breast cancer; drug screening; oncology; cancer research; temsirolimus; genome analysis; regulatory mechanism; cancer cell; drug response; gefitinib; tumor cell; genomics; outcomes research; malignant neoplastic disease; dna microarray; microenvironment; molecular biology; tumor; oblimersen; human; priority journal; gcs 100; n sec butyl 1 (2 chlorophenyl) n methyl 3 isoquinolinecarboxamide
Journal Title: Seminars in Oncology
Volume: 31
Issue: Suppl.16
ISSN: 0093-7754
Publisher: Elsevier Inc.  
Date Published: 2004-12-01
Start Page: 33
Language: English
DOI: 10.1053/j.seminoncol.2004.10.017
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 16 June 2014 -- CODEN: SOLGA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David R Spriggs
    325 Spriggs